Drug Type Recombinant polypeptide |
Synonyms |
Target |
Mechanism CD200 inhibitors(OX-2 membrane glycoprotein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization OX2 Therapeutics, Inc.Startup |
Active Organization OX2 Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Recurrent Glioblastoma | Phase 1 | US | OX2 Therapeutics, Inc.Startup | 01 Dec 2020 |